Efficacy and safety of fenebrutinib vs teriflunomide in relapsing multiple sclerosis: Results of the FENhance 1 and 2 studies

Authors
Category Primary study
Conference12th Congress of the European Academy of Neurology
Year 2026
This article has no abstract
Epistemonikos ID: 3b8011627200a7a8f53fbaab538e3cd04f6ba73d
First added on: Sep 12, 2026